Abstract
摘要
相似文献
1
Sabril--a new antiepileptic agent.
S Afr Med J. 1994 Oct;84(10):33, 38.
2
[Vigabatrin in the treatment of pediatric epileptic syndrome].
Harefuah. 1995 Mar 1;128(5):306-8.
3
Vigabatrin.氨己烯酸
Pediatr Nurs. 1998 Jul-Aug;24(4):357-61.
4
[Vigabatrin symposium within the congress "Epilepsy Europe", 3 September 1992, Glasgow].
Nervenarzt. 1992 Dec;63(12 Suppl):1-12.
5
[Vigabatrin--a new antiepileptic agent].
Tidsskr Nor Laegeforen. 1994 Oct 10;114(24):2843-4.
6
[Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
Clin Ter. 1998 Mar-Apr;149(2):131-4.
7
[Some new problems in the pharmacologic treatment of epilepsy].
Pol Tyg Lek. 1994;49(4-5):118-21.
8
Vigabatrin.氨己烯酸
Epilepsia. 1994;35 Suppl 5:S25-8. doi: 10.1111/j.1528-1157.1994.tb05962.x.
9
The new antiepileptic drugs.新型抗癫痫药物。
Arch Dis Child Educ Pract Ed. 2007 Dec;92(6):182-8. doi: 10.1136/adc.2007.106880.
10
Vigabatrin causes profound reduction in serum alanine transaminase activity.氨己烯酸可使血清丙氨酸转氨酶活性大幅降低。
Ann Clin Biochem. 1996 May;33 ( Pt 3):257-8. doi: 10.1177/000456329603300314.
Zotero 插件